Chuan-tao S. Zuo

12 Middle Wulumuqi Road
Shanghai, 200040, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 84 publications

An exploratory 18F-Florzolotau tau PET study in putative body-first versus brain-first Parkinson's disease.

An exploratory 18F-Florzolotau tau PET study in putative body-first versus brain-first Parkinson's disease.

Journal: European journal of nuclear medicine and molecular imaging

Published: April 21, 2026

Caudate-Predominant Striatal Dopaminergic Deficit Distinguishes Behavioral Variant of Frontotemporal Dementia With Parkinsonism From Other Parkinsonian Syndromes.

Caudate-Predominant Striatal Dopaminergic Deficit Distinguishes Behavioral Variant of Frontotemporal Dementia With Parkinsonism From Other Parkinsonian Syndromes.

Journal: Clinical nuclear medicine

Published: April 07, 2026

Brain Metabolic Signatures of Amyloid-β and Tau Pathology in Corticobasal Syndrome: A Multimodal Biomarker Study.

Brain Metabolic Signatures of Amyloid-β and Tau Pathology in Corticobasal Syndrome: A Multimodal Biomarker Study.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: March 11, 2026

White matter 18F-florbetapir retention predicts cognitive decline and treatment response in Alzheimer's disease.

White matter 18F-florbetapir retention predicts cognitive decline and treatment response in Alzheimer's disease.

Journal: Alzheimer's research & therapy

Published: March 04, 2026

Diagnostic impact of tau versus amyloid PET in patients with cognitive symptoms.

Diagnostic impact of tau versus amyloid PET in patients with cognitive symptoms.

Journal: Brain : a journal of neurology

Published: January 26, 2026

Individualized cortico-basal ganglia-thalamo-cortical circuit dysfunction links striatal dopaminergic loss to motor symptom severity in Parkinson's disease.

Individualized cortico-basal ganglia-thalamo-cortical circuit dysfunction links striatal dopaminergic loss to motor symptom severity in Parkinson's disease.

Journal: NPJ Parkinson's disease

Published: January 13, 2026

Individual gray-white matter functional connection predicts tau spread and cognitive decline in Alzheimer's disease.

Individual gray-white matter functional connection predicts tau spread and cognitive decline in Alzheimer's disease.

Journal: NeuroImage

Published: January 02, 2026

A unified deep learning framework for cross-platform harmonization of multi-tracer PET quantification in neurodegenerative disease.

A unified deep learning framework for cross-platform harmonization of multi-tracer PET quantification in neurodegenerative disease.

Journal: NPJ digital medicine

Published: November 19, 2025

Multimodal neuroimaging elucidates the posterior-to-anterior gradient of nigrostriatal degeneration in Parkinson's disease.

Multimodal neuroimaging elucidates the posterior-to-anterior gradient of nigrostriatal degeneration in Parkinson's disease.

Journal: NPJ Parkinson's disease

Published: November 05, 2025

Utility of 18F-Florzolotau PET as a prognostic and monitoring biomarker in a memory clinic cohort.

Utility of 18F-Florzolotau PET as a prognostic and monitoring biomarker in a memory clinic cohort.

Journal: Alzheimer's research & therapy

Published: September 15, 2025

Stratifying amyloid burden in early Alzheimer's disease using cascaded attention-guided vision transformer using [¹⁸F]Florbetapir PET.

Stratifying amyloid burden in early Alzheimer's disease using cascaded attention-guided vision transformer using [¹⁸F]Florbetapir PET.

Journal: European radiology

Published: August 27, 2025

Safety and short-term outcomes of lecanemab for Alzheimer's disease in China: a multicentre study.

Safety and short-term outcomes of lecanemab for Alzheimer's disease in China: a multicentre study.

Journal: Brain : a journal of neurology

Published: August 14, 2025

Showing 1-12 of 84

Last Updated: 09/26/2026